World

Top 413 largest Companies in the Drug Manufacturers—Specialty & Generic industry in the World by Market Cap

This is the list of the largest public listed companies in the Drug Manufacturers—Specialty & Generic industry in the world by market capitalization with links to their reference stock.

World Drug Manufacturers—Specialty & Generic Industry Analysis
World Top Companies World Companies Analysis

Top 1-year algo backtest: +327.04%

$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Top Drug Manufacturers—Specialty & Generic Companies in the World as of Jan. 01, 2025

Rank Company Market Cap (USD) Country Sector Industry
301 Morishita Jintan Co. Ltd $54.0 M Japan Japanese Healthcare Japanese Drug Manufacturers—Specialty & Generic
302 Diurnal Group plc $53.3 M

(Oct. 1, 2022)

 United Kingdom UK Healthcare UK Drug Manufacturers—Specialty & Generic
303 Cannara Biotech, Inc. $53.2 M Canada Canadian Healthcare Canadian Drug Manufacturers—Specialty & Generic
304 ECO Animal Health Group plc $53.1 M United Kingdom UK Healthcare UK Drug Manufacturers—Specialty & Generic
305 Wakamoto Pharmaceutical Co.,Ltd. $51.8 M Japan Japanese Healthcare Japanese Drug Manufacturers—Specialty & Generic
306 Winston Medical Supply Co.,Ltd $51.2 M Taiwan Taiwanese Healthcare Taiwanese Drug Manufacturers—Specialty & Generic
307 iAnthus Capital Holdings, Inc. $50.0 M United States US Healthcare US Drug Manufacturers—Specialty & Generic
308 Allied Biotech Corp $49.7 M Taiwan Taiwanese Healthcare Taiwanese Drug Manufacturers—Specialty & Generic
309 Ayr Wellness, Inc. $46.6 M United States US Healthcare US Drug Manufacturers—Specialty & Generic
310 MariMed, Inc. $46.1 M United States US Healthcare US Drug Manufacturers—Specialty & Generic
311 Medexus Pharmaceuticals, Inc. $45.8 M Canada Canadian Healthcare Canadian Drug Manufacturers—Specialty & Generic
312 Anxo Pharmaceutical Co. Ltd $44.7 M Taiwan Taiwanese Healthcare Taiwanese Drug Manufacturers—Specialty & Generic
313 SCYNEXIS, Inc. $40.6 M United States US Healthcare US Drug Manufacturers—Specialty & Generic
314 Enzymatica AB $40.5 M

(July 1, 2024)

 Sweden Swedish Healthcare Swedish Drug Manufacturers—Specialty & Generic
315 Next Science Limited $38.8 M

(July 1, 2024)

 Australia Australian Healthcare Australian Drug Manufacturers—Specialty & Generic
316 Qilian International Holding Group Limited $38.7 M

(Oct. 1, 2024)

 China Chinese Healthcare Chinese Drug Manufacturers—Specialty & Generic
317 InnoCan Pharma Corp $36.5 M Canada Canadian Healthcare Canadian Drug Manufacturers—Specialty & Generic
318 Comvita Ltd $32.2 M New Zealand NZ Healthcare NZ Drug Manufacturers—Specialty & Generic
319 Shield Therapeutics plc $31.2 M United Kingdom UK Healthcare UK Drug Manufacturers—Specialty & Generic
320 Cronos Australia Limited $31.2 M

(July 1, 2024)

 Australia Australian Healthcare Australian Drug Manufacturers—Specialty & Generic
321 Flora Growth Corp $26.5 M Canada Canadian Healthcare Canadian Drug Manufacturers—Specialty & Generic
322 PT Indofarma $24.3 M Indonesia Indonesian Healthcare Indonesian Drug Manufacturers—Specialty & Generic
323 Leviathan Cannabis Group, Inc. $20.5 M Canada Canadian Healthcare Canadian Drug Manufacturers—Specialty & Generic
324 Medical Developments International Limited $19.0 M

(July 1, 2024)

 Australia Australian Healthcare Australian Drug Manufacturers—Specialty & Generic
325 Provexis plc $16.9 M United Kingdom UK Healthcare UK Drug Manufacturers—Specialty & Generic
326 Teligent, Inc. $16.1 M

(June 1, 2022)

 United States US Healthcare US Drug Manufacturers—Specialty & Generic
327 Mithra Pharmaceuticals SA $15.5 M

(July 1, 2024)

 Belgium Belgian Healthcare Belgian Drug Manufacturers—Specialty & Generic
328 ProPhase Labs, Inc. $12.9 M United States US Healthcare US Drug Manufacturers—Specialty & Generic
329 Jupiter Wellness, Inc. $12.8 M

(July 1, 2023)

 United States US Healthcare US Drug Manufacturers—Specialty & Generic
330 Eagle Pharmaceuticals, Inc. $12.7 M United States US Healthcare US Drug Manufacturers—Specialty & Generic

Top Drug Manufacturers—Specialty & Generic Companies in the World as of Jan. 01, 2025

301. Morishita Jintan Co. Ltd

Company Profile: Morishita Jintan Co. Ltd
Market Cap (USD): $54.0 M
Country: Japan
Sector: Japanese Healthcare
Industry: Japanese Drug Manufacturers—Specialty & Generic

302. Diurnal Group plc

Company Profile: Diurnal Group plc
Market Cap (USD): $53.3 M (Oct. 1, 2022)
Country: United Kingdom
Sector: UK Healthcare
Industry: UK Drug Manufacturers—Specialty & Generic

303. Cannara Biotech, Inc.

Company Profile: Cannara Biotech, Inc.
Market Cap (USD): $53.2 M
Country: Canada
Sector: Canadian Healthcare
Industry: Canadian Drug Manufacturers—Specialty & Generic

304. ECO Animal Health Group plc

Company Profile: ECO Animal Health Group plc
Market Cap (USD): $53.1 M
Country: United Kingdom
Sector: UK Healthcare
Industry: UK Drug Manufacturers—Specialty & Generic

305. Wakamoto Pharmaceutical Co.,Ltd.

Company Profile: Wakamoto Pharmaceutical Co.,Ltd.
Market Cap (USD): $51.8 M
Country: Japan
Sector: Japanese Healthcare
Industry: Japanese Drug Manufacturers—Specialty & Generic

306. Winston Medical Supply Co.,Ltd

Company Profile: Winston Medical Supply Co.,Ltd
Market Cap (USD): $51.2 M
Country: Taiwan
Sector: Taiwanese Healthcare
Industry: Taiwanese Drug Manufacturers—Specialty & Generic

307. iAnthus Capital Holdings, Inc.

Company Profile: iAnthus Capital Holdings, Inc.
Market Cap (USD): $50.0 M
Country: United States
Sector: US Healthcare
Industry: US Drug Manufacturers—Specialty & Generic

308. Allied Biotech Corp

Company Profile: Allied Biotech Corp
Market Cap (USD): $49.7 M
Country: Taiwan
Sector: Taiwanese Healthcare
Industry: Taiwanese Drug Manufacturers—Specialty & Generic

309. Ayr Wellness, Inc.

Company Profile: Ayr Wellness, Inc.
Market Cap (USD): $46.6 M
Country: United States
Sector: US Healthcare
Industry: US Drug Manufacturers—Specialty & Generic

310. MariMed, Inc.

Company Profile: MariMed, Inc.
Market Cap (USD): $46.1 M
Country: United States
Sector: US Healthcare
Industry: US Drug Manufacturers—Specialty & Generic

311. Medexus Pharmaceuticals, Inc.

Company Profile: Medexus Pharmaceuticals, Inc.
Market Cap (USD): $45.8 M
Country: Canada
Sector: Canadian Healthcare
Industry: Canadian Drug Manufacturers—Specialty & Generic

312. Anxo Pharmaceutical Co. Ltd

Company Profile: Anxo Pharmaceutical Co. Ltd
Market Cap (USD): $44.7 M
Country: Taiwan
Sector: Taiwanese Healthcare
Industry: Taiwanese Drug Manufacturers—Specialty & Generic

313. SCYNEXIS, Inc.

Company Profile: SCYNEXIS, Inc.
Market Cap (USD): $40.6 M
Country: United States
Sector: US Healthcare
Industry: US Drug Manufacturers—Specialty & Generic

314. Enzymatica AB

Company Profile: Enzymatica AB
Market Cap (USD): $40.5 M (July 1, 2024)
Country: Sweden
Sector: Swedish Healthcare
Industry: Swedish Drug Manufacturers—Specialty & Generic

315. Next Science Limited

Company Profile: Next Science Limited
Market Cap (USD): $38.8 M (July 1, 2024)
Country: Australia
Sector: Australian Healthcare
Industry: Australian Drug Manufacturers—Specialty & Generic

316. Qilian International Holding Group Limited

Company Profile: Qilian International Holding Group Limited
Market Cap (USD): $38.7 M (Oct. 1, 2024)
Country: China
Sector: Chinese Healthcare
Industry: Chinese Drug Manufacturers—Specialty & Generic

317. InnoCan Pharma Corp

Company Profile: InnoCan Pharma Corp
Market Cap (USD): $36.5 M
Country: Canada
Sector: Canadian Healthcare
Industry: Canadian Drug Manufacturers—Specialty & Generic

318. Comvita Ltd

Company Profile: Comvita Ltd
Market Cap (USD): $32.2 M
Country: New Zealand
Sector: NZ Healthcare
Industry: NZ Drug Manufacturers—Specialty & Generic

319. Shield Therapeutics plc

Company Profile: Shield Therapeutics plc
Market Cap (USD): $31.2 M
Country: United Kingdom
Sector: UK Healthcare
Industry: UK Drug Manufacturers—Specialty & Generic

320. Cronos Australia Limited

Company Profile: Cronos Australia Limited
Market Cap (USD): $31.2 M (July 1, 2024)
Country: Australia
Sector: Australian Healthcare
Industry: Australian Drug Manufacturers—Specialty & Generic

321. Flora Growth Corp

Company Profile: Flora Growth Corp
Market Cap (USD): $26.5 M
Country: Canada
Sector: Canadian Healthcare
Industry: Canadian Drug Manufacturers—Specialty & Generic

322. PT Indofarma

Company Profile: PT Indofarma
Market Cap (USD): $24.3 M
Country: Indonesia
Sector: Indonesian Healthcare
Industry: Indonesian Drug Manufacturers—Specialty & Generic

323. Leviathan Cannabis Group, Inc.

Company Profile: Leviathan Cannabis Group, Inc.
Market Cap (USD): $20.5 M
Country: Canada
Sector: Canadian Healthcare
Industry: Canadian Drug Manufacturers—Specialty & Generic

324. Medical Developments International Limited

Company Profile: Medical Developments International Limited
Market Cap (USD): $19.0 M (July 1, 2024)
Country: Australia
Sector: Australian Healthcare
Industry: Australian Drug Manufacturers—Specialty & Generic

325. Provexis plc

Company Profile: Provexis plc
Market Cap (USD): $16.9 M
Country: United Kingdom
Sector: UK Healthcare
Industry: UK Drug Manufacturers—Specialty & Generic

326. Teligent, Inc.

Company Profile: Teligent, Inc.
Market Cap (USD): $16.1 M (June 1, 2022)
Country: United States
Sector: US Healthcare
Industry: US Drug Manufacturers—Specialty & Generic

327. Mithra Pharmaceuticals SA

Company Profile: Mithra Pharmaceuticals SA
Market Cap (USD): $15.5 M (July 1, 2024)
Country: Belgium
Sector: Belgian Healthcare
Industry: Belgian Drug Manufacturers—Specialty & Generic

328. ProPhase Labs, Inc.

Company Profile: ProPhase Labs, Inc.
Market Cap (USD): $12.9 M
Country: United States
Sector: US Healthcare
Industry: US Drug Manufacturers—Specialty & Generic

329. Jupiter Wellness, Inc.

Company Profile: Jupiter Wellness, Inc.
Market Cap (USD): $12.8 M (July 1, 2023)
Country: United States
Sector: US Healthcare
Industry: US Drug Manufacturers—Specialty & Generic

330. Eagle Pharmaceuticals, Inc.

Company Profile: Eagle Pharmaceuticals, Inc.
Market Cap (USD): $12.7 M
Country: United States
Sector: US Healthcare
Industry: US Drug Manufacturers—Specialty & Generic

Top 1-year algo backtest: +327.04% - Try Disfold DeepFinance for FREE now!

Stay in touch